Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report

Publisher： Karger

E-ISSN： 1663-2699|7|2|389-397

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.7, Iss.2, 2016-09, pp. : 389-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cystoid Macular Edema in Retinitis Pigmentosa Patients without Associated Macular Thickening

By Gorovoy Ian R.  

Seminars in Ophthalmology, Vol. 28, Iss. 2, 2013-03 ,pp. : 79-83

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Ranibizumab (Lucentis) for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Clinical Control Trials

By Wang Haiyan   Sun Xiaodong   Liu Kun   Xu Xun  

Current Eye Research, Vol. 37, Iss. 8, 2012-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 370-375

Karger

Access to resources Recommend Favorite

Comparison of Topical Dorzolamide and Ketorolac Treatment for Cystoid Macular Edema in Retinitis Pigmentosa and Usher's Syndrome

By  

Ophthalmologica, Vol. 233, Iss. 1, 2014-11 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite